I am a Healthcare Professional outside the US and UK

I am a Healthcare Professional outside the US and UK

Click here for international medical scientific information about Oncology for Healthcare Professionals.

I am not a Healthcare Professional and I am outside the US and the UK

I am not a Healthcare Professional and I am outside the US and the UK

Click here for general international information for patients, caregivers and the general public.

Country-specific medical scientific information

Country-specific medical scientific information

Country-specific medical scientific information for Healthcare Professionals.

This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information

InOncology.com

ASCO, CHICAGO, IL, USA, 31 May-4 JUNE 2019

XENERA™-1: A phase II trial of xentuzumab in combination with everolimus and exemestane in patients with hormone-receptor positive, human epidermal growth factor receptor-2-negative metastatic breast cancer and non-visceral involvement

Peter Schmid, Hope S. Rugo, Javier Cortés, Dennis Chin-Lun Huang, Kate Crossley, Dan Massey, Howard A. Burris

FOR HEALTHCARE PROFESSIONALS ONLY.

image